Header Logo

Connection

ERIC SCHAFER to Vidarabine

Back to Details
This is a "connection" page, showing publications ERIC SCHAFER has written about Vidarabine.
ERIC SCHAFER
Connection Strength
0.197
Vidarabine
  1. Real-world experience in treating pediatric relapsed/refractory or therapy-related myeloid malignancies with decitabine, vorinostat, and FLAG therapy based on a phase 1 study run by the TACL consortium. Pediatr Blood Cancer. 2022 10; 69(10):e29812.
    View in: PubMed
    Score: 0.197
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.